Skip to content

The German Itch Questionnaire, validation in different diagnoses

The German Itch Questionnaire, validation in different diagnoses

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013971
Enrollment
360
Registered
2018-04-23
Start date
2018-01-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urticaria, psoriasis, atopic eczema, patients with pruritus and kidney disease, patients with pruritus and liver disease, patients with pruritus and chronic prurigo, pruritus of multifactorial genesis, somatoform pruritus or neuropahtic pruritus L29.8 L29.9 F45.8

Interventions

Group 1: Patients with chronic itch will be questioned one or to times with five modules: general anamnesis, itch-specific anamnesis, itch-specific therapy, itch-specific quality of life and sleep. Si

Sponsors

Universitätsklinikum Heidelberg,Verantwortlich für Organisation der Studie und Ethikantrag / Responsible for organisation of study and ethics committee application: Prof. Elke Weisshaar
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - patients with chronic pruritus >= 6 weeks - written informed consent - personal introduction in the study center - capacity for consent

Exclusion criteria

Exclusion criteria: - deficient knowledge of the language - limited vigilance, e.g. dementia, sedatives

Design outcomes

Primary

MeasureTime frame
Hypothesis: Because of the itch-specific anamnesis, the questionnaire can differentiate between different diagnoses. The present study should provide intial approches of the validity. Therefore, construct validity and criterion validity will be assesd.

Secondary

MeasureTime frame
On a subsample, the retest-reliability of the itch-specific anamnesis will be assessed after 24 hours. On a second subsample, the sensitivity to change/ stability will be assessed after 1 week.

Countries

Austria, Germany, Switzerland

Contacts

Public ContactElke Weisshaar

Universitätsklinikum Heidelberg, Berufsdermatologie

Elke.Weisshaar@med.uni-heidelberg.de06221/568752

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026